Song L, Healy D P
Department of Pharmacology, Mount Sinai School of Medicine of the City University of New York, New York, NY, USA.
Hypertension. 1999 Feb;33(2):746-52. doi: 10.1161/01.hyp.33.2.746.
Aminopeptidase A (APA) is the principal enzyme that metabolizes angiotensin II (Ang II) to angiotensin III. Previously, we showed that kidney APA was elevated in spontaneously hypertensive rats and was reduced after angiotensin-converting enzyme inhibition. In the present study, we sought to determine whether kidney APA expression was altered after chronically elevated Ang II, either exogenously delivered via osmotic minipumps or endogenously produced in two-kidney, one clip (2K1C) hypertensive rats. Ang II (200 ng. kg-1. min-1) was infused subcutaneously for 1 or 2 weeks by osmotic minipumps, and 2K1C rats were tested 4 weeks after unilateral renal artery clipping. Blood pressure was not significantly elevated in the Ang II-infused animals but was significantly increased at 3 and 4 weeks in the 2K1C animals. APA was significantly elevated approximately 2-fold in kidney cortical membranes from Ang II-infused animals but was decreased 45% in the clipped kidney and 18% in the nonclipped kidneys from 2K1C animals. Isolated glomeruli from Ang II-infused animals and the nonclipped kidneys from 2K1C animals had markedly higher APA activity and immunoreactivity. Likewise, histochemical and immunohistochemical studies indicated that APA levels were increased in glomeruli from angiotensin-infused animals and in both nonclipped and clipped kidneys from 2K1C animals. In contrast, tubular APA was decreased in tubular elements from 2K1C animals, most markedly in the clipped kidneys. Thus, despite the increase in glomerular APA expression in kidneys from 2K1C animals, the decrease in tubular APA expression is more extensive and accounts for the measured reduction in total APA in cortical homogenates. Because clipped kidneys are not exposed to high blood pressure, these results suggest that glomerular APA expression is positively regulated and tubular APA negatively regulated by Ang II. These results further suggest that changes in kidney APA expression could influence the progression of angiotensin-dependent hypertension.
氨肽酶A(APA)是将血管紧张素II(Ang II)代谢为血管紧张素III的主要酶。此前,我们发现自发性高血压大鼠肾脏中的APA升高,而在血管紧张素转换酶抑制后降低。在本研究中,我们试图确定在慢性升高的Ang II后,肾脏APA表达是否发生改变,Ang II通过渗透微型泵外源性给予,或在两肾一夹(2K1C)高血压大鼠体内内源性产生。通过渗透微型泵皮下输注Ang II(200 ng·kg-1·min-1)1或2周,2K1C大鼠在单侧肾动脉夹闭4周后进行检测。输注Ang II的动物血压没有显著升高,但2K1C动物在3周和4周时血压显著升高。输注Ang II的动物肾脏皮质膜中的APA显著升高约2倍,但2K1C动物夹闭肾中的APA降低45%,未夹闭肾中的APA降低18%。来自输注Ang II的动物和2K1C动物未夹闭肾的分离肾小球具有明显更高的APA活性和免疫反应性。同样,组织化学和免疫组织化学研究表明,输注血管紧张素的动物肾小球以及2K1C动物未夹闭和夹闭肾中的APA水平均升高。相反,2K1C动物肾小管中的管状APA降低,在夹闭肾中最为明显。因此,尽管2K1C动物肾脏中肾小球APA表达增加,但管状APA表达的降低更为广泛,这解释了皮质匀浆中总APA的测量降低。由于夹闭肾未暴露于高血压,这些结果表明肾小球APA表达受Ang II正调控,而管状APA受负调控。这些结果进一步表明,肾脏APA表达的变化可能影响血管紧张素依赖性高血压 的进展。